David E. Kaelin

731 total citations
14 papers, 483 citations indexed

About

David E. Kaelin is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, David E. Kaelin has authored 14 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in David E. Kaelin's work include Synthetic Organic Chemistry Methods (6 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). David E. Kaelin is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotic Resistance in Bacteria (4 papers). David E. Kaelin collaborates with scholars based in United States, China and Japan. David E. Kaelin's co-authors include Stephen F. Martin, Omar D. Lopez, I.M. Fellows, B. Michael O’Keefe, Douglas M. Mans, Steven M. Sparks, Hilary R. Plake, Leo S. Geraci, Matthias Schneider and Thomas A. Kirkland and has published in prestigious journals such as Journal of the American Chemical Society, Tetrahedron and Tetrahedron Letters.

In The Last Decade

David E. Kaelin

14 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Kaelin United States 10 383 192 122 48 40 14 483
Tsuyoshi Ogiku Japan 15 445 1.2× 349 1.8× 62 0.5× 25 0.5× 29 0.7× 45 657
Norma Dunlap United States 11 206 0.5× 166 0.9× 36 0.3× 17 0.4× 25 0.6× 27 353
Marta Nevalainen United States 13 450 1.2× 265 1.4× 219 1.8× 16 0.3× 74 1.9× 16 577
AV Rama Rao India 16 426 1.1× 208 1.1× 131 1.1× 32 0.7× 58 1.4× 25 521
P. Ramya India 12 371 1.0× 197 1.0× 56 0.5× 20 0.4× 8 0.2× 29 480
Marco Boccalini Italy 13 372 1.0× 114 0.6× 113 0.9× 18 0.4× 12 0.3× 23 483
Norma J. Tom United States 11 405 1.1× 197 1.0× 70 0.6× 25 0.5× 18 0.5× 12 533
Oee‐Sook Park South Korea 10 364 1.0× 98 0.5× 143 1.2× 21 0.4× 10 0.3× 22 452
James K. Sutherland United Kingdom 14 381 1.0× 171 0.9× 91 0.7× 23 0.5× 34 0.8× 56 519
P. DI CESARE France 10 229 0.6× 142 0.7× 45 0.4× 11 0.2× 10 0.3× 21 298

Countries citing papers authored by David E. Kaelin

Since Specialization
Citations

This map shows the geographic impact of David E. Kaelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kaelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kaelin more than expected).

Fields of papers citing papers by David E. Kaelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Kaelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kaelin. The network helps show where David E. Kaelin may publish in the future.

Co-authorship network of co-authors of David E. Kaelin

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Kaelin. A scholar is included among the top collaborators of David E. Kaelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Kaelin. David E. Kaelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Singh, Sheo B., Christopher M. Tan, David E. Kaelin, et al.. (2022). Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9). Bioorganic & Medicinal Chemistry Letters. 75. 128808–128808. 3 indexed citations
2.
Singh, Sheo B., David E. Kaelin, Peter T. Meinke, et al.. (2015). Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5). Bioorganic & Medicinal Chemistry Letters. 25(17). 3630–3635. 14 indexed citations
3.
Singh, Sheo B., David E. Kaelin, Jin Wu, et al.. (2015). C1–C2-linker substituted 1,5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7). MedChemComm. 6(10). 1773–1780. 8 indexed citations
4.
Singh, Sheo B., David E. Kaelin, Jin Wu, et al.. (2014). Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents. ACS Medicinal Chemistry Letters. 5(5). 609–614. 58 indexed citations
5.
O’Keefe, B. Michael, Douglas M. Mans, David E. Kaelin, & Stephen F. Martin. (2011). Studies toward the syntheses of pluramycin natural products. The first total synthesis of isokidamycin. Tetrahedron. 67(35). 6524–6538. 31 indexed citations
6.
Martin, Stephen F., et al.. (2011). Total Synthesis of Isokidamycin. Synfacts. 2011(2). 127–127. 1 indexed citations
7.
O’Keefe, B. Michael, Douglas M. Mans, David E. Kaelin, & Stephen F. Martin. (2010). Total Synthesis of Isokidamycin. Journal of the American Chemical Society. 132(44). 15528–15530. 57 indexed citations
8.
Kaelin, David E., George J. Eiermann, Huaibing He, et al.. (2007). 4-Arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 17(21). 5806–5811. 17 indexed citations
9.
Kaelin, David E. & Richard W. Prugh. (2006). Explosible dusts, US codes and standards of safe management practices. Process Safety Progress. 25(4). 298–302. 3 indexed citations
10.
Kaelin, David E., Steven M. Sparks, Hilary R. Plake, & Stephen F. Martin. (2003). Regioselective Synthesis of Unsymmetrical C-Aryl Glycosides Using Silicon Tethers as Disposable Linkers. Journal of the American Chemical Society. 125(43). 12994–12995. 46 indexed citations
11.
Apsel, Beth, et al.. (2003). General entries to C-aryl glycosides. Formal synthesis of galtamycinone. Tetrahedron Letters. 44(5). 1075–1077. 38 indexed citations
12.
Kirkland, Thomas A., John Colucci, Leo S. Geraci, et al.. (2001). Total Synthesis of (+)-Ambruticin S. Journal of the American Chemical Society. 123(49). 12432–12433. 58 indexed citations
13.
Kaelin, David E., Omar D. Lopez, & Stephen F. Martin. (2001). General Strategies for the Synthesis of the Major Classes of C-Aryl Glycosides. Journal of the American Chemical Society. 123(28). 6937–6938. 78 indexed citations
14.
Fellows, I.M., David E. Kaelin, & Stephen F. Martin. (2000). Application of Ring-Closing Metathesis to the Formal Total Synthesis of (+)−FR900482. Journal of the American Chemical Society. 122(44). 10781–10787. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026